PRICE MICHAEL DENNIS 4
4 · AKCEA THERAPEUTICS, INC. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
PRICE MICHAEL DENNIS
Chief Financial Officer
Transactions
- Disposition from Tender
Common Stock
2020-10-12$18.15/sh−50,000$907,500→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$3.37/sh−300,000$1,011,000→ 0 totalExercise: $14.78Exp: 2030-05-17→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This option, which provided that 1/4th of the shares would vest one year after May 18, 2020 and that 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $1,011,000.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.